Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acoziborole for Human African Trypanosomiasis (Sleeping Sickness)
NCT03087955Phase 3Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Oct 2016
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of acoziborole in human African trypanosomiasis (HAT), sponsored by Drugs for Neglected Diseases initiative. Started Oct 2016; status: completed.
02
Drugs
acoziborole
03
Conditions
human African trypanosomiasis (HAT)
Beyond the preview
Go deeper on NCT03087955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03087955.